Publications by authors named "Walter Fiers"

Claim this Profile
O
Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus.
Lei Deng, Kenny Roose, Emma R Job, Riet De Rycke, Evelien Van Hamme, Walter Fiers

J Control Release· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection.
Jochen Pendzialek, Kenny Roose, Anouk Smet, Bert Schepens, Peter Kufer, Walter Fiers

Antiviral Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M2-based influenza vaccines: recent advances and clinical potential.
Annasaheb Kolpe, Bert Schepens, Walter Fiers, Xavier Saelens

Expert Rev Vaccines· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies.
Michael Schotsaert, Tine Ysenbaert, Anouk Smet, Bert Schepens, Dieter Vanderschaeghe, Walter Fiers

Sci Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.
Sarah De Baets, Judith Verhelst, Silvie Van den Hoecke, Anouk Smet, Michael Schotsaert, Walter Fiers

PLoS One· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.
Lei Deng, Lorena Itatí Ibañez, Veronique Van den Bossche, Kenny Roose, Sameh A Youssef, Walter Fiers

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody.
Ki Joon Cho, Bert Schepens, Kristof Moonens, Lei Deng, Walter Fiers

J Virol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses.
Judith Verhelst, Jan Spitaels, Cindy Nürnberger, Dorien De Vlieger, Tine Ysenbaert, Walter Fiers

J Virol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody.
Ki Joon Cho, Bert Schepens, Jong Hyeon Seok, Sella Kim, Kenny Roose, Walter Fiers

J Virol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M2e-Based Universal Influenza A Vaccines.
Lei Deng, Ki Joon Cho, Walter Fiers, Xavier Saelens

Vaccines (Basel)· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.
Bert Schepens, Koen Sedeyn, Liesbeth Vande Ginste, Sarah De Baets, Michael Schotsaert, Walter Fiers

EMBO Mol Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.
Francisco Miguel Cardoso, Lorena Itatí Ibañez, Silvie Van den Hoecke, Sarah De Baets, Anouk Smet, Walter Fiers

J Virol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.
Lorena Itatí Ibañez, Kenny Roose, Marina De Filette, Michael Schotsaert, Jessica De Sloovere, Walter Fiers

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.
Hana Kammoun, Xavier Roux, Dominique Raze, Anne-Sophie Debrie, Marina De Filette, Walter Fiers

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.
Sarah De Baets, Bert Schepens, Koen Sedeyn, Michael Schotsaert, Kenny Roose, Walter Fiers

J Virol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly.
Judith Verhelst, Eef Parthoens, Bert Schepens, Walter Fiers, Xavier Saelens

J Virol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlling influenza by cytotoxic T-cells: calling for help from destroyers.
Michael Schotsaert, Lorena Itatí Ibañez, Walter Fiers, Xavier Saelens

J Biomed Biotechnol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine research in Belgium.
Walter Fiers

Cytokine Growth Factor Rev· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus.
Dubravka Grdic Eliasson, Anja Helgeby, Karin Schön, Caroline Nygren, Karim El-Bakkouri, Walter Fiers

Vaccine· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective.
Marina De Filette, Tine Ysenbaert, Kenny Roose, Michael Schotsaert, Stefan Roels, Walter Fiers

J Gen Virol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.
Karim El Bakkouri, Francis Descamps, Marina De Filette, Anouk Smet, Els Festjens, Walter Fiers

J Immunol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M2e-based universal influenza A vaccine.
Walter Fiers, Marina De Filette, Karim El Bakkouri, Bert Schepens, Kenny Roose

Vaccine· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.
Michael Schotsaert, Marina De Filette, Walter Fiers, Xavier Saelens

Expert Rev Vaccines· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pandemic preparedness: toward a universal influenza vaccine.
Kenny Roose, Walter Fiers, Xavier Saelens

Drug News Perspect· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
Marina De Filette, Wouter Martens, Anouk Smet, Michael Schotsaert, Ashley Birkett, Walter Fiers

Vaccine· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis